In this clip from The Call @ Hedgeye, Healthcare analyst William McMahon discusses Omicron ramping and its impact on testing, staffing and labor, noting Acadia Healthcare Company, Inc. (ACHC) and Quest Diagnostics (DGX).
“Dr. Fauci came out this weekend and said while cases are ramping to this incredible level, what we should be focused on more is the disproportionate amount of hospitalizations and deaths resulting from this wave. That’s something we have called out throughout the process,” notes McMahon.
(This clip is a small taste of what our subscribers get each day on The Call @ Hedgeye. In a nutshell, The Call is our morning research call hosted by Hedgeye CEO Keith McCullough with our 40+ analyst research team. It helps small and large investors alike make better decisions via unique and investable stock/sector updates Click here to learn more.)